ambroxol has been researched along with Hepatitis in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Hepatitis: INFLAMMATION of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khoury, T | 1 |
| Ishay, Y | 1 |
| Rotnemer-Golinkin, D | 1 |
| Zolotarovya, L | 1 |
| Arkadir, D | 1 |
| Zimran, A | 1 |
| Ilan, Y | 1 |
1 other study available for ambroxol and Hepatitis
| Article | Year |
|---|---|
A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders.
Topics: Ambroxol; Animals; Anti-Inflammatory Agents; Concanavalin A; Cytokines; Disease Models, Animal; Drug | 2020 |